Alerts will be sent to your verified email
Verify EmailSHUKRAPHAR
Shukra Pharma
|
Syncom Formulations
|
Bajaj Healthcare
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
11.12 % | 8.81 % | 8.79 % |
5yr average Equity Multiplier
|
2.18 | 1.5 | 2.22 |
5yr Average Asset Turnover Ratio
|
0.6 | 0.79 | 0.84 |
5yr Avg Net Profit Margin
|
7.6 % | 7.78 % | 3.88 % |
Price to Book
|
24.49 | 4.52 | 3.25 |
P/E
|
152.1 | 26.85 | 32.18 |
5yr Avg Cash Conversion Cycle
|
-20.3 Days | 84.02 Days | 130.36 Days |
Inventory Days
|
31.54 Days | 27.61 Days | 79.52 Days |
Days Receivable
|
133.87 Days | 123.89 Days | 145.27 Days |
Days Payable
|
381.54 Days | 93.18 Days | 94.44 Days |
5yr Average Interest Coverage Ratio
|
36.02 | 39.83 | 6.35 |
5yr Avg ROCE
|
10.67 % | 12.74 % | 22.78 % |
5yr Avg Operating Profit Margin
|
15.03 % | 9.47 % | 17.36 % |
5 yr average Debt to Equity
|
0.32 | 0.2 | 0.86 |
5yr CAGR Net Profit
|
241.36 % | 19.56 % | -13.82 % |
5yr Average Return on Assets
|
6.5 % | 5.89 % | 4.81 % |
Shareholdings
|
|||
Promoter Holding
|
50.96 % | 50.57 % | 59.19 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
1.79 % | 0.0 | -8.11 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 1.66 % |
Shukra Pharma
|
Syncom Formulations
|
Bajaj Healthcare
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|